Evidence map›Paper›PMID 28681074›Full record

ArticleEuropean radiology2018

Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.

Yin Xi, Qing Yuan, Yue Zhang, Ananth J Madhuranthakam, Michael Fulkerson, Vitaly Margulis, James Brugarolas, Payal Kapur, Jeffrey A Cadeddu, Ivan Pedrosa

Open access · greenAbstract read
In one paragraph

Article in European radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Quantitative Methods in Abdominal MRI: Perfusion Imaging.Topics in magnetic resonance imaging : TMRI · 2017
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yin XiDepartment of Radiology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, 75235-9085, USA.
Qing YuanDepartment of Radiology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, 75235-9085, USA.
Yue ZhangDepartment of Radiology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, 75235-9085, USA.
Ananth J MadhuranthakamDepartment of Radiology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, 75235-9085, USA.
Michael FulkersonDepartment of Radiology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, 75235-9085, USA.
Vitaly MargulisDepartment of Urology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, USA.
James BrugarolasKidney Cancer Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, USA.
Payal KapurDepartment of Urology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, USA.
Jeffrey A CadedduDepartment of Urology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, USA.
Ivan PedrosaDepartment of Radiology, UT Southwestern Medical Center, 2201 Inwood Road, Dallas, TX, 75235-9085, USA. Ivan.Pedrosa@UTSouthwestern.edu.
The University of Texas Southwestern Medical Center · USSouthwestern Medical CenterAdvanced Imaging Research (United States) · USSouthwestern Medical Center · US

Funding

University of Texas Southwestern Medical Center SPORE in Kidney CancerP50CA196516 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI James Brugarolas · 2016 to 2026
$24.7M
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMAR01CA154475 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI PEDROSA, IVAN · 2011 to 2024
$4.3M
NCI NIH HHS P50 CA196516NCI NIH HHS R01 CA154475
6 · The paper itself

Abstract

objectivesTo apply a statistical clustering algorithm to combine information from dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) into a single tumour map to distinguish high-grade from low-grade T1b clear cell renal cell carcinoma (ccRCC).

methodsThis prospective, Institutional Review Board -approved, Health Insurance Portability and Accountability Act -compliant study included 18 patients with solid T1b ccRCC who underwent pre-surgical DCE MRI. After statistical clustering of the parametric maps of the transfer constant between the intravascular and extravascular space (K

resultsSeven high-grade and 11 low-grade T1b ccRCCs were included. High-grade histology was associated with higher percent high active areas (p = 0.0154) and this was the only feature selected by the decision tree model, which had a diagnostic performance of 78% accuracy, 86% sensitivity, 73% specificity, 67% positive predictive value and 89% negative predictive value.

conclusionsThe FCM integrates multiple DCE-derived parameter maps and identifies tumour regions with unique pharmacokinetic characteristics. Using this approach, a decision tree model using criteria beyond size to predict tumour grade in T1b ccRCCs is proposed. KEY POINTS: • Tumour size did not correlate with tumour grade in T1b ccRCC. • Tumour heterogeneity can be analysed using statistical clustering via DCE-MRI parameters. • High-grade ccRCC has a larger percentage of high active area than low-grade ccRCCs. • A decision-tree model offers a simple way to differentiate high/low-grade ccRCCs.

Indexed as

Contrast MediaDecision TreesAlgorithmsArea Under CurveCarcinoma, Renal CellFemaleHumansImage EnhancementKidney NeoplasmsMagnetic Resonance ImagingMaleMiddle AgedNeoplasm GradingProspective StudiesSensitivity and SpecificityContrast MediaClear-cell renal cell carcinomaDynamic contrast-enhanced-MRIKidney cancerStatistical clusteringTumour heterogeneity

Identifiers

PMID28681074
PMCPMC5718968
OpenAlexW2725658070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.